Licensing deal signed with Tepnel Life Sciences

Two-year agreement supports Abcam’s range of kits and other non-antibody products

Cambridge, UK, 1 May 2008 – Abcam has extended its global licensing agreement with Tepnel Life Sciences. The two-year deal means that Abcam will continue to distribute Tepnel’s Diaclone range of products to scientists worldwide.

The agreement supports Abcam’s growing range of non-antibody products, which now includes proteins, peptides, kits, slides and lysates.